Accessibility Menu
Co-Diagnostics logo

Co-Diagnostics

(NASDAQ) CODX

Current Price$8.29
Market Cap$30.73M
Since IPO (2017)-95%
5 Year-100%
1 Year-97%
1 Month+458%

Co-Diagnostics Financials at a Glance

Market Cap

$30.73M

Revenue (TTM)

$718.17K

Net Income (TTM)

-$48.50M

EPS (TTM)

-$28.01

P/E Ratio

-0.30

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$8.29

Volume

58,653

Open

$11.76

Previous Close

$8.29

Daily Range

$8.20 - $13.53

52-Week Range

$1.26 - $1,395.00

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Co-Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

115

CEO

Dwight Howard Egan

Website

co-dx.com

Headquarters

Salt Lake City, UT 84109, US

CODX Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

-44%

Net Income Margin

-68%

Return on Equity

-152%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-3.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$30.73M

Shares Outstanding

3.60M

Volume

58.65K

Avg. Volume

7.22M

Financials (TTM)

Gross Profit

$400.11K

Operating Income

-$31.28M

EBITDA

-$30.18M

Operating Cash Flow

-$29.14M

Capital Expenditure

-$700.05K

Free Cash Flow

-$29.84M

Cash & ST Invst.

$11.88M

Total Debt

$1.24M

Co-Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$145.95K

+190.3%

Gross Profit

-$303.26K

-1157.1%

Gross Margin

-2.08%

N/A

Market Cap

$30.73M

N/A

Market Cap/Employee

$232.80K

N/A

Employees

132

N/A

Net Income

-$9.14M

-21.3%

EBITDA

-$8.95M

-8.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$6.20M

-68.3%

Accounts Receivable

$82.39K

-39.6%

Inventory

$846.12K

-21.9%

Long Term Debt

$1.17M

+14.0%

Short Term Debt

$857.64K

-5.0%

Return on Assets

-2.26%

N/A

Return on Invested Capital

-1.86%

N/A

Free Cash Flow

-$7.99M

+9.6%

Operating Cash Flow

-$7.85M

+10.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ADGMAdagio Medical Holdings, Inc.
$0.72-0.17%
SINTSintx Technologies, Inc.
$2.24+1.82%
TNONTenon Medical, Inc.
$0.69-1.12%
VVOSVivos Therapeutics, Inc.
$0.70+4.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$211.14-0.01%
INTCIntel
$114.68-0.05%
SPCEVirgin Galactic
$6.18+0.36%
ONDSOndas
$13.22-0.00%

Questions About CODX

What is the current price of Co-Diagnostics?

Co-Diagnostics is trading at $8.29 per share.

What is the 52-week range for Co-Diagnostics?

Over the past 52 weeks, Co-Diagnostics has traded between $1.26 and $1,395.00.

How much debt does Co-Diagnostics have?

As of the most recent reporting period, Co-Diagnostics reported total debt of $2.03M.

How much cash does Co-Diagnostics have on hand?

Co-Diagnostics reported $8.23M in cash and cash equivalents in its most recent financial results.

What is Co-Diagnostics’s dividend yield?

Co-Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.